Fluxo W7M vs Leviatan Prediction & Odds — CBLOL (Jul 26, 2026)

TL;DR: Fluxo W7M 75.5% vs Leviatan 24.5%. The clearest reason is the bot-lane advantage: BAO is posting a 5.7 KDA, +383 GD@15, and 30.9% damage share, while Leviatan have struggled to survive early deficits across the map.

This is not a matchup between two in-form teams, but Fluxo still arrive with the steadier profile. They are 7W-11L and sixth in CBLOL, while Leviatan sit 6W-13L in seventh, and both teams are only 1W-4L over their last five series. The difference is that Fluxo’s losses have at least come with more competitive individual lanes and a clearer route to winning through the bottom side, whereas Leviatan’s average gold deficit of -10,003 is a major warning sign in a league where early control often decides the map. Fluxo’s own early game is far from clean at -3,520 average gold diff, but that still looks manageable compared with Leviatan conceding 18.7 kills per game.

The player matchup that stands out most is BAO against Snaker, because Fluxo’s bot carry has been the one consistent pressure point even in defeats. Momochi also helps stabilize that lane with 87.5% kill participation and a +128 GD@15, giving Fluxo a foundation for contesting first objectives. Elsewhere, cody and Peach have shaky lane numbers, but they remain more reliable than Leviatan’s collapsing core of Booki and Enga, whose recent KDA trends are both declining. For Leviatan, the concern is that even when Enga keeps 82.5% kill participation, it has not translated into stable mid-game setups.

Draft should reinforce that gap. In the current CBLOL meta, Varus carries 78.7% presence with a 64% ban rate, while Orianna sits at 71.9% presence and 53.4% ban, so both should shape the first ban phase. If Ryze is left open, that is a strong candidate for an early priority pick given its 80% WR over 10 games as a B1 option, and Fluxo look better equipped to play around that kind of structured setup. Jarvan IV, Rumble, and Pantheon also remain central, but Fluxo have shown more coherent ways to connect those picks to side-lane tempo.

Polymarket is the strongest outside signal here, pricing Fluxo W7M at 75.5% and Leviatan at 24.5%. That split makes sense because the market is reading the same picture the stats show: Fluxo are flawed, but Leviatan are losing harder early, dying more often, and lack a dependable carry profile comparable to BAO.

There is no notable head-to-head edge in the provided data, which makes current form, lane trends, and draft fit the real story. Fluxo W7M 75.5% vs Leviatan 24.5% feels like the right call because Fluxo’s bottom side gives them the clearest win condition in a series where both teams otherwise look fragile.

FAQ